Modern views on β-adrenoblocker therapy in elderly patients with chronic heart failure

Modern views on β-adrenoblocker therapy in elderly patients with chronic heart failure

Chronic heart failure (CHF) prevalence is maximal in the elderly. There are some important practical aspects of β-adrenoblocker therapy in this patient group. SENIORS study results provide new data on selective β-adrenoblocker / NO-dependent vasodilator nebivolol therapy perspectives in CHF patients...

Full description

Saved in:

Bibliographic Details
Main Author:	E. V. Privalova
Format:	Article
Language:	Russian
Published:	«SILICEA-POLIGRAF» LLC 2007-06-01
Series:	Кардиоваскулярная терапия и профилактика
Subjects:	chronic heart failure elderly patients β-adrenoblockers nebivolol
Online Access:	https://cardiovascular.elpub.ru/jour/article/view/1269
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

RATIONAL CHOICE OF Β-ADRENOBLOCKERS IN CHRONIC HEART FAILURE THERAPY
by: M. L. Maximov
Published: (2015-12-01)

Differential beta-adrenoblocker therapy in chronic heart failure
by: S. N. Tereshchenko, et al.
Published: (1970-01-01)

Modern therapeutic potential of super-selective β<sup>1</sup>-adrenoblocker nebivolol
by: V. I. Makolkin, et al.
Published: (1970-01-01)

EFFECTS OF BETA-BLOCKER METOPROLOL ON QUALITY OF LIFE IN ELDERLY PATIENTS WITH CHRONIC HEART FAILURE
by: I. V. Vologdina
Published: (2015-12-01)

CHRONIC HEART FAILURE OF ISCHEMIC GENESIS AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE: POSSIBILITIES OF COMBINATION THERAPY INCLUDING NEBIVOLOL
by: P. A. Fedotov, et al.
Published: (2014-07-01)

THE PLACE OF NEBIVOLOL IN RATIONAL THERAPY OF CONGESTIVE HEART FAILURE
by: A. B. Khadzegova
Published: (2014-09-01)

URODYNAMIC EFFECTS OF BETA-ADRENOBLOCKERS: NEBIVOLOL ADVANTAGES
by: M. P. Savenkov, et al.
Published: (2016-01-01)

Beta-adrenoblocker in heart failure: bisoprolol role
by: Yu. V. Lukina, et al.
Published: (1970-01-01)

Differential approach in selecting beta-adrenoblocker therapy for patients with chronic heart failure and anaemia
by: T. M. Uskach, et al.
Published: (2012-04-01)

Rational pharmacotherapy of chronic heart failure with increased endothelin-1 activity: beta-adrenoblocker nebivolol place
by: L. I. Olbinskaya, et al.
Published: (2007-02-01)

Pharmacokinetics and pharmacodynamics of a β-adrenoblocker bisoprolol: from mechanisms of action to clinical features
by: O. D. Ostroumova, et al.
Published: (2011-06-01)

Benefits of vasodilating beta-adrenoblockers for arterial hypertension treatment
by: V. B. Mychka
Published: (2012-06-01)

Cardioselective beta-adrenoblocker bisoprolol in treating hypertensive patients with heart failure
by: A. N. Britov
Published: (2005-06-01)

Target organs in patients with post-infarction chronic heart failure: dynamics during complex therapy including beta-adrenoblockers
by: I. P. Rubesh, et al.
Published: (2008-08-01)

Differential beta-adrenoblocker therapy in chronic heart failure: the role of age, gender, and co-morbidity
by: S. N. Tereshchenko, et al.
Published: (2009-10-01)

Microcirculation in arterial hypertension patients receiving beta-adrenoblockers
by: L. L. Kirichenko, et al.
Published: (2006-12-01)

Beta-adrenoblockers in clinical practice: is there any difference?
by: D. V. Nebieridze, et al.
Published: (2007-06-01)

FACTORS EFFECTING THE DECOMPENSATION OF CHRONIC HEART FAILURE IN THE ELDERLY
by: V. N. Larina, et al.
Published: (2015-09-01)

Combination antihypertensive therapy in patients with arterial hypertension and coronary heart disease
by: T. E. Morozova, et al.
Published: (2013-08-01)

Stable coronary heart disease treatment: focus on beta-adrenoblockers
by: V. I. Makolkin
Published: (2008-12-01)

REASONS FOR Β-ADRENOBLOCKER USE IN ARTERIAL HYPERTENSION: ONE MORE TIME ABOUT PRO AND CONTRA
by: V. I. Makolkin
Published: (2016-01-01)

NEBIVOLOL ROLE IN THE CORRECTION OF INTRACARDIAC HEMODYNAMICS IN PATIENTS WITH CHRONIC HEART FAILURE
by: R. L. Dzhanaeva, et al.
Published: (2012-02-01)

Current position of beta-adrenoblockers in coronary heart disease management: information for clinicians
by: I. A. Libov, et al.
Published: (2009-04-01)

Beta-adrenoblockers in coronary heart disease patients. Evidencebased medicine data
by: A. E. Radzevich, et al.
Published: (1970-01-01)

Heart rate-reducing agents ivabradine and beta-adrenoblockers in the management of patients with stable effort angina
by: Z. M. Galeeva, et al.
Published: (2011-02-01)

Clinical efficacy of nebivolol and metoprolol in complex treatment of patients with coronary heart disease and II-III functional class chronic heart failure
by: A. G. Evdokimova, et al.
Published: (2005-04-01)

ROLE OF MEDICATIONS WITH NEGATIVE CHRONOTROPIC EFFECT IN THE TREATMENT OF PATIENTS WITH CORONARY HEART DISEASE AND HEART FAILURE
by: M. G. Glezer, et al.
Published: (2013-10-01)

Carvedilol and bisoprolol effectiveness in patients with myocardial infarction and heart failure
by: A. I. Chesnikova, et al.
Published: (2008-06-01)

Pleiotropic activity of antihypertensives in atherothrombogenesis. Nebivolol: increasing possibilities and reducing restrictions
by: M. G. Bubnova
Published: (2008-12-01)

Status and function of betaDadrenoreceptors and their modification during betaDblocker treatment in patients with arterial hypertension and chronic heart failure
by: O. A. Maneshina, et al.
Published: (2005-10-01)

TREATMENT FOR CHRONIC HEART FAILURE IN ELDERLY SUBJECTS
by: A. S. Poskrebysheva, et al.
Published: (2014-07-01)

THE USAGE OF METOPROLOL TARTRATE IN ELDERLY AND OLD PATIENTS WITH CORONARY HEART DISEASE COMPLICATED BY CHRONIC HEART FAILURE
by: E. B. Nagaytseva, et al.
Published: (2003-06-01)

Modern management of arterial hypertension: has the position of beta-adrenoblockers changed
by: S. Yu. Martsevich
Published: (2007-08-01)

Effects of interventions on the readiness for hospital discharge in elderly patients with chronic heart failure: a randomized controlled trial
by: Min Shan, et al.
Published: (2025-08-01)

Heart rate reduction as a therapeutic goal: focus on primary prevention
by: Yu. A. Orlova, et al.
Published: (2012-02-01)

Nebivolol effects on myocardial remodelling, inflammation markers and endothelial dysfunction in chronic heart failure patients with or without Type 2 diabetes mellitus
by: Yu. N. Belenkov, et al.
Published: (2011-02-01)

Long-term carvedilol therapy effects on left ventricular remodeling and glycemia in patients with chronic heart failure and Type 2 diabetes mellitus
by: R. R. Samedov, et al.
Published: (2008-02-01)

OPTIMIZATION OF CHRONIC HEART FAILURE DIAGNOSTICS IN ELDERLY PATIENTS
by: L. I. Malinova, et al.
Published: (2011-06-01)

Beta-adrenoblockers in cardiology practice
by: A. A. Garganeeva
Published: (2010-10-01)

Simvastatin therapy in elderly patients with chronic heart failure: potential cardiodepressive effects
by: A. L. Pirogov, et al.
Published: (2008-10-01)